Skip to main content

Advertisement

SpringerLink
Log in

Preoperative imaging for locoregional staging of bladder cancer

  • Special Section: Urothelial Disease
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Bladder cancer is the ninth most common cancer, expected to lead to an estimated 17,670 deaths in the United States in 2019. Clinical management and prognosis of bladder cancer mainly depend on the extent of locoregional disease, particularly whether bladder muscle is involved. Therefore, bladder cancer is often divided into superficial, non-muscle-invasive bladder cancer and muscle-invasive bladder cancer; the latter often prompts consideration for cystectomy. While precise staging prior to cystectomy is crucial, the optimal preoperative imaging modality used to stage the disease remains controversial. Transurethral resection of bladder tumor (TURBT) followed by computed tomography (CT) urography is the current recommended approach for staging bladder cancer but suffers from a high rate of understaging. We review the recent literature and compare different imaging modalities for assessing the presence of muscle invasion and lymph node involvement prior to cystectomy and highlight the advantages of each modality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA: a cancer journal for clinicians 69(1):7-34.

    Google Scholar 

  2. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: bladder cancer. Version 5.2018.

  3. van der Pol CB, Sahni VA, Eberhardt SC, Oto A, Akin O, Alexander LF, Allen BC, Coakley FV, Froemming AT, Fulgham PF, Hosseinzadeh K (2018) ACR appropriateness criteria® pretreatment staging of muscle-invasive bladder cancer. Journal of the American College of Radiology 15(5):S150-9.

    PubMed  Google Scholar 

  4. Young FP, Ende D, Epstein RJ (2018) Beyond BCG: the approaching era of personalised bladder-sparing therapies for non-muscle-invasive urothelial cancers. Future Oncology 15(4):409-20.

    PubMed  Google Scholar 

  5. Abdelsalam EM, Adalany MA, Fouda ME (2018) Value of diffusion weighted magnetic resonance imaging in grading of urinary bladder carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 49(2):509-18.

    Google Scholar 

  6. van der Pol CB, Shinagare AB, Tirumani SH, Preston MA, Vangel MG, Silverman SG (2018) Bladder cancer local staging: multiparametric MRI performance following transurethral resection. Abdominal Radiology 43(9):2412-23.

    PubMed  Google Scholar 

  7. Ark JT, Keegan KA, Barocas DA, Morgan TM, Resnick MJ, You C, Cookson MS, Penson DF, Davis R, Clark PE, Smith Jr JA (2014) Incidence and predictors of understaging in patients with clinical T 1 urothelial carcinoma undergoing radical cystectomy. BJU international 113(6):894-9.

    PubMed  PubMed Central  Google Scholar 

  8. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (2017) AJCC Cancer Staging Manual. 8th ed. New York: Springer

    Google Scholar 

  9. Hafeez S, Huddart R (2013) Advances in bladder cancer imaging. BMC medicine 11(1):104.

    PubMed  PubMed Central  Google Scholar 

  10. Thoeny HC, Froehlich JM, Triantafyllou M, Huesler J, Bains LJ, Vermathen P, Fleischmann A, Studer UE (2014) Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology 273(1):125-35.

    PubMed  Google Scholar 

  11. Bostrom PJ, Van Rhijn BW, Fleshner N, Finelli A, Jewett M, Thoms J, Hanna S, Kuk C, Zlotta AR (2010) Staging and staging errors in bladder cancer. European Urology Supplements 9(1):2-9.

    Google Scholar 

  12. Sadow CA, Silverman SG, O’Leary MP, Signorovitch JE (2008) Bladder cancer detection with CT urography in an Academic Medical Center. Radiology 249(1):195-202.

    PubMed  Google Scholar 

  13. Lee CH, Tan CH, Faria SD, Kundra V (2017) Role of imaging in the local staging of urothelial carcinoma of the bladder. American Journal of Roentgenology 208(6):1193-205.

    PubMed  Google Scholar 

  14. Mossanen M, Chang SL, Kimm S, Sonpavde GP, Kibel AS (2018) Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. The Urologic clinics of North America 45(2):143-54.

    PubMed  Google Scholar 

  15. Caterino M, Giunta S, Finocchi V, Giglio L, Mainiero G, Carpanese L, Crecco M (2001) Primary cancer of the urinary bladder: CT evaluation of the T parameter with different techniques. Abdominal imaging 26(4):433-8.

    CAS  PubMed  Google Scholar 

  16. Pichler R, De Zordo T, Fritz J, Kroiss A, Aigner F, Heidegger I, Virgolini I, Horninger W, Uprimny C (2017) Pelvic lymph node staging by combined 18F-FDG-PET-CT imaging in bladder cancer prior to radical cystectomy. Clinical genitourinary cancer 15(3):e387-95.

    PubMed  Google Scholar 

  17. Li Y, Diao F, Shi S, Li K, Zhu W, Wu S, Lin T (2018) Computed tomography and magnetic resonance imaging evaluation of pelvic lymph node metastasis in bladder cancer. Chinese journal of cancer 37(1):3.

    PubMed  PubMed Central  Google Scholar 

  18. Schmid SC, Zahel T, Haller B, Horn T, Metzger I, Holzapfel K, Seitz AK, Gschwend JE, Retz M, Maurer T (2016) Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival. World journal of urology 34(4):569-76.

    PubMed  Google Scholar 

  19. Kim JK, Park SY, Ahn HJ, Kim CS, Cho KS (2004) Bladder cancer: analysis of multi–detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. Radiology 231(3):725-31.

    PubMed  Google Scholar 

  20. Baltaci S, Resorlu B, Yagcı C, Turkolmez K, Gogus C, Beduk Y (2008) Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urologia internationalis 81(4):399-402.

    PubMed  Google Scholar 

  21. Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y (2010) Evaluation of fluorodeoxyglucose positron‐emission tomography with computed tomography for staging of urothelial carcinoma. BJU international 106(5):658-63.

    PubMed  Google Scholar 

  22. Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P (2010) FDG-PET-CT for the preoperative lymph node staging of invasive bladder cancer. European urology 57(4):641-7.

    PubMed  Google Scholar 

  23. Maurer T, Souvatzoglou M, Kübler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M (2012) Diagnostic efficacy of [11C] choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. European urology 61(5):1031-8.

    PubMed  Google Scholar 

  24. Hitier‐Berthault M, Ansquer C, Branchereau J, Renaudin K, Bodere F, Bouchot O, Rigaud J (2013) 18 F‐fluorodeoxyglucose positron emission tomography–computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: A prospective study. International Journal of Urology 20(8):788-96.

    CAS  PubMed  Google Scholar 

  25. Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A (2012) Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. Urology 79(6):1317-21.

    PubMed  Google Scholar 

  26. Nayak B, Dogra PN, Naswa N, Kumar R (2013) Diuretic 18 F-FDG PET-CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. European journal of nuclear medicine and molecular imaging 40(3):386-93.

    CAS  PubMed  Google Scholar 

  27. Goodfellow H, Viney Z, Hughes P, Rankin S, Rottenberg G, Hughes S, Evison F, Dasgupta P, O’Brien T, Khan MS (2014) Role of fluorodeoxyglucose positron emission tomography (FDG PET)‐computed tomography (CT) in the staging of bladder cancer. BJU international 114(3):389-95.

    CAS  PubMed  Google Scholar 

  28. Aljabery F, Lindblom G, Skoog S, Shabo I, Olsson H, Rosell J, Jahnson S (2015) PET-CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer. BMC urology 15(1):87.

    PubMed  PubMed Central  Google Scholar 

  29. Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS (2015) FDG PET–CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Annals of surgical oncology 22(9):3150-6.

    PubMed  Google Scholar 

  30. Horn T, Zahel T, Adt N, Schmid SC, Heck MM, Thalgott MK, Hatzichristodoulou G, Haller B, Autenrieth M, Kübler HR, Gschwend JE (2016) Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy. Urologia internationalis 96(1):51-6.

    CAS  PubMed  Google Scholar 

  31. Oz II, Altinbas NK, Serifoglu I, Oz EB, Yagci C (2016) The role of computerized tomography in the assessment of perivesical invasion in bladder cancer. Polish journal of radiology 81:281.

    PubMed  PubMed Central  Google Scholar 

  32. van der Pol CB, Chung A, Lim C, Gandhi N, Tu W, Mclnnes MD, Schieda N (2018) Update on multiparametric MRI of urinary bladder cancer. Journal of Magnetic Resonance Imaging 48(4):882-96.

    PubMed  Google Scholar 

  33. Panebianco V, De Berardinis E, Barchetti G, Simone G, Leonardo C, Grompone MD, Del Monte M, Carano D, Gallucci M, Catto J, Catalano C (2017) An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer. European radiology 27(9):3759-66.

    PubMed  Google Scholar 

  34. Takeuchi M, Sasaki S, Naiki T, Kawai N, Kohri K, Hara M, Shibamoto Y (2013) MR imaging of urinary bladder cancer for T‐staging: A review and a pictorial essay of diffusion‐weighted imaging. Journal of Magnetic Resonance Imaging 38(6):1299-309.

    PubMed  Google Scholar 

  35. Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K, Thompson R, Bluemke D (2005) Dynamic MRI of bladder cancer: evaluation of staging accuracy. American Journal of Roentgenology 184(1):121-7.

    PubMed  Google Scholar 

  36. Papalia R, Simone G, Grasso R, Augelli R, Faiella E, Guaglianone S, Cazzato R, Vescovo RD, Ferriero M, Zobel B, Gallucci M (2012) Diffusion‐weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases. BJU international 109(7):1031-6.

    PubMed  Google Scholar 

  37. de Haas RJ, Steyvers MJ, Fütterer JJ (2014) Multiparametric MRI of the bladder: ready for clinical routine?. American Journal of Roentgenology 202(6):1187-95.

    PubMed  Google Scholar 

  38. Sevcenco S, Ponhold L, Heinz-Peer G, Fajkovic H, Haitel A, Susani M, Shariat SF, Szarvas T, Baltzer PA (2014) Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness. InUrologic Oncology: Seminars and Original Investigations (Vol. 32, No. 8, pp. 1166-1171). Elsevier.

  39. Barsoum N, Talaat M, Saraya S (2017) Can diffusion-weighted MRI predict the histological grade of urinary bladder carcinoma?. Kasr Al Ainy Medical Journal 23(2):86.

    Google Scholar 

  40. Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, Suzuki K, Oshima H, Hara M, Shibamoto Y (2009) Urinary bladder cancer: diffusion-weighted MR imaging—accuracy for diagnosing T stage and estimating histologic grade. Radiology 251(1):112-21.

    PubMed  Google Scholar 

  41. Wu LM, Chen XX, Xu JR, Zhang XF, Suo ST, Yao QY, Fan Y, Hu J (2013) Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. Academic radiology 20(8):939-46.

  42. Rabie E, Faeghi F, Izadpanahi MH, Dayani MA (2016) Role of dynamic contrast-enhanced magnetic resonance imaging in staging of bladder cancer. Journal of clinical and diagnostic research: JCDR 10(4):TC01.

  43. Bagheri MH, Ahlman MA, Lindenberg L, Turkbey B, Lin J, Civelek AC, Malayeri AA, Agarwal PK, Choyke PL, Folio LR, Apolo AB (2017) Advances in medical imaging for the diagnosis and management of common genitourinary cancers. InUrologic Oncology: Seminars and Original Investigations (Vol. 35, No. 7, pp. 473-491). Elsevier.

  44. Gupta N, Sureka B, Kumar MM, Malik A, Bhushan TB, Mohanty NK (2015) Comparison of dynamic contrast-enhanced and diffusion weighted magnetic resonance image in staging and grading of carcinoma bladder with histopathological correlation. Urology annals 7(2):199.

    PubMed  PubMed Central  Google Scholar 

  45. Sankineni S, Brown AM, Fascelli M, Law YM, Pinto PA, Choyke PL, Turkbey B (2015) Lymph node staging in prostate cancer. Current urology reports 16(5):30.

    PubMed  PubMed Central  Google Scholar 

  46. Triantafyllou M, Studer UE, Birkhäuser FD, Fleischmann A, Bains LJ, Petralia G, Christe A, Froehlich JM, Thoeny HC (2013) Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. European journal of cancer 49(3):616-24.

    CAS  PubMed  Google Scholar 

  47. Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, Vermathen P, Fleischmann A, Thoeny HC (2013) Combined ultrasmall superparamagnetic particles of iron oxide–enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. European urology 64(6):953-60.

    PubMed  Google Scholar 

  48. Rajesh A, Sokhi HK, Fung R, Mulcahy KA, Bankart MJ (2011) Bladder cancer: evaluation of staging accuracy using dynamic MRI. Clinical radiology 66(12):1140-5.

    CAS  PubMed  Google Scholar 

  49. Ghafoori M, Shakiba M, Ghiasi A, Asvadi N, Hosseini K, Alavi M (2013) Value of MRI in local staging of bladder cancer. Urology journal 10(2):866-72.

    PubMed  Google Scholar 

  50. Zytoon AA, Azab SM, Samak WA (2017) Role of magnetic resonance in evaluation of urinary bladder cancer. Menoufia Medical Journal 30(1):104.

    Google Scholar 

  51. Lee M, Shin SJ, Oh YT, Jung DC, Cho NH, Choi YD, Park SY (2017) Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. European radiology 27(9):3752-8.

    PubMed  Google Scholar 

  52. Hameed HA, Nagi MA, Wali DH (2018) Role of Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Assessment of Urinary Bladder Carcinoma. The Egyptian Journal of Hospital Medicine (July 2018)72(11):5561-70.

  53. Watanabe H, Kanematsu M, Kondo H, Goshima S, Tsuge Y, Onozuka M, Moriyama N (2009) Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?. American Journal of Roentgenology 192(5):1361-6.

    PubMed  Google Scholar 

  54. Daneshmand S, Ahmadi H, Huynh LN, Dobos N (2012) Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology 80(6):1313-8.

    PubMed  Google Scholar 

  55. Rosenkrantz AB, Friedman KP, Ponzo F, Raad RA, Jackson K, Huang WC, Balar AV (2017) Prospective pilot study to evaluate the incremental value of PET information in patients with bladder cancer undergoing 18F-FDG simultaneous PET-MRI. Clinical nuclear medicine 42(1):e8.

    PubMed  PubMed Central  Google Scholar 

  56. Agarwal KK, Roy SG, Kumar R (2016) Diuretic 18F-Fluorodeoxyglucose PET/computed tomography in evaluation of genitourinary malignancies. PET clinics 11(1):39-46.

    PubMed  Google Scholar 

  57. Koyama K, Okamura T, Kawabe J, Ozawa N, Torii K, Umesaki N, Miyama M, Ochi H, Yamada R (2003) Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors. Journal of Nuclear Medicine 44(3):353-8.

    PubMed  Google Scholar 

  58. Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L (2005) FDG-PET for preoperative staging of bladder cancer. European journal of nuclear medicine and molecular imaging 32(12):1412-7.

    CAS  PubMed  Google Scholar 

  59. Mertens LS, Fioole‐Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S (2013) Impact of 18 F‐fluorodeoxyglucose (FDG)‐positron‐emission tomography/computed tomography (PET-CT) on management of patients with carcinoma invading bladder muscle. BJU international 112(6):729-34.

    CAS  PubMed  Google Scholar 

  60. Kollberg P, Almquist H, Bläckberg M, Cronberg C, Garpered S, Gudjonsson S, Kleist J, Lyttkens K, Patschan O, Liedberg F(2015) [18 F] Fluorodeoxyglucose–positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy. Scandinavian journal of urology 49(4):296-301.

    PubMed  Google Scholar 

  61. Kassem TW. Up and down staging of TCC using 18F-FDG PET-CT scan (2016) The Egyptian Journal of Radiology and Nuclear Medicine 47(3):1095-102.

  62. Lee ST, Lawrentschuk N, Scott AM (2012) PET in prostate and bladder tumors. InSeminars in nuclear medicine (Vol. 42, No. 4, pp. 231-246). WB Saunders.

  63. Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON (2012) 11C-acetate PET-CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline. Clinical nuclear medicine 37(4):e67-72.

    PubMed  Google Scholar 

  64. Picchio M, Treiber U, Beer AJ, Metz S, Bössner P, Van Randenborgh H, Paul R, Weirich G, Souvatzoglou M, Hartung R, Schwaiger M (2006) Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. Journal of Nuclear Medicine 47(6):938-44.

    CAS  PubMed  Google Scholar 

  65. Golan S, Sopov V, Baniel J, Groshar D (2011) Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study. The Journal of urology 186(2):436-41.

    PubMed  Google Scholar 

  66. Apolo AB, Riches J, Schöder H, Akin O, Trout A, Milowsky MI, Bajorin DF (2010) Clinical value of fluorine-18 2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography in bladder cancer. Journal of Clinical Oncology 28(25):3973.

    PubMed  PubMed Central  Google Scholar 

  67. Vind-Kezunovic S, Bouchelouche K, Ipsen P, Høyer S, Bell C, Jensen JB (2017) Detection of lymph node metastasis in patients with bladder cancer using maximum standardised uptake value and 18F-fluorodeoxyglucose positron emission tomography/computed tomography: results from a high-volume centre including long-term follow-up. European urology focus

  68. Rosenkrantz AB, Friedman K, Chandarana H, Melsaether A, Moy L, Ding YS, Jhaveri K, Beltran L, Jain R (2016) Current status of hybrid PET-MRI in oncologic imaging. American Journal of Roentgenology 206(1):162-72.

    PubMed  Google Scholar 

  69. Catalano OA, Rosen BR, Sahani DV, Hahn PF, Guimaraes AR, Vangel MG, Nicolai E, Soricelli A, Salvatore M (2013) Clinical impact of PET-MRI imaging in patients with cancer undergoing same-day PET-CT: initial experience in 134 patients—a hypothesis-generating exploratory study. Radiology 269(3):857-69.

    PubMed  Google Scholar 

  70. Salminen A, Jambor I, Merisaari H, Ettala O, Virtanen J, Koskinen I, Veskimae E, Sairanen J, Taimen P, Kemppainen J, Minn H (2018) 11 C-acetate PET-MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial). Cancer Imaging 18(1):25.

    PubMed  PubMed Central  Google Scholar 

  71. Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, Siegel C, Cao D, Gao F, Siegel BA (2009) Prospective study of [18F] fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. Journal of Clinical Oncology 27(26):4314.

    PubMed  PubMed Central  Google Scholar 

  72. Schöder H, Ong SC, Reuter VE, Cai S, Burnazi E, Dalbagni G, Larson SM, Bochner BH (2012) Initial results with 11 C-acetate positron emission tomography/computed tomography (PET-CT) in the staging of urinary bladder cancer. Molecular Imaging and Biology 14(2):245-51.

    PubMed  Google Scholar 

  73. Ceci F, Bianchi L, Graziani T, Castellucci P, Pultrone C, Eugenio B, Martorana G, Colletti PM, Rubello D, Fanti S, Schiavina R (2015) 11C-choline PET-CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. Clinical nuclear medicine 40(2):e124-8.

    PubMed  Google Scholar 

  74. Brunocilla E, Ceci F, Schiavina R, Castellucci P, Maffione AM, Cevenini M, Bianchi L, Borghesi M, Giunchi F, Fiorentino M, Chondrogiannis S (2014) Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings. Clinical nuclear medicine 39(5):e308-12.

    PubMed  Google Scholar 

  75. Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR (2016) The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World journal of urology 34(9):1229-37.

    PubMed  Google Scholar 

  76. Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, Huddart R, Kennish S, Lerner S, Montironi R, Muglia VF (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). European urology 74(3):294-306.

    PubMed  PubMed Central  Google Scholar 

  77. Barchetti G, Simone G, Ceravolo I, Salvo V, Campa R, Del Giudice F, De Berardinis E, Buccilli D, Catalano C, Gallucci M, Catto JW (2019) Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center. European radiology 1-9.

  78. Wang H, Luo C, Zhang F, Guan J, Li S, Yao H, Chen J, Luo J, Chen L, Guo Y (2019) Multiparametric MRI for bladder cancer: validation of VI-RADS for the detection of detrusor muscle invasion. Radiology 182506.

  79. Ueno Y, Takeuchi M, Tamada T, Sofue K, Takahashi S, Kamishima Y, Hinata N, Harada K, Fujisawa M, Murakami T (2019) Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study. European Urology.

  80. Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V (2013) Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266(1):177-84.

    PubMed  Google Scholar 

  81. Ganeshan B, Abaleke S, Young RC, Chatwin CR, Miles KA (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer imaging 10(1):137.

    PubMed  PubMed Central  Google Scholar 

  82. Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clinical radiology 67(2):157-64.

    CAS  PubMed  Google Scholar 

  83. Lim CS, Tirumani S, van der Pol CB, Alessandrino F, Sonpavde GP, Silverman SG, Shinagare AB (2019) Use of Quantitative T2-Weighted and Apparent Diffusion Coefficient Texture Features of Bladder Cancer and Extravesical Fat for Local Tumor Staging After Transurethral Resection. American Journal of Roentgenology 1-0.

  84. Sun H, Shi B, Jin ZY, Xue HD (2017). Quantitative CT texture analysis for evaluating histologic grade of urothelial carcinoma. Abdominal Radiology 42(2): 561-8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, USA

    S. Mojdeh Mirmomen & Ashkan A. Malayeri

  2. Dana-Farber Cancer Institute, Boston, MA, USA

    Atul B. Shinagare & Kristin E. Williams

  3. Department of Radiology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, USA

    Atul B. Shinagare, Kristin E. Williams, Stuart G. Silverman & Ashkan A. Malayeri

Authors
  1. S. Mojdeh Mirmomen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atul B. Shinagare
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kristin E. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stuart G. Silverman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ashkan A. Malayeri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashkan A. Malayeri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mirmomen, S.M., Shinagare, A.B., Williams, K.E. et al. Preoperative imaging for locoregional staging of bladder cancer. Abdom Radiol 44, 3843–3857 (2019). https://doi.org/10.1007/s00261-019-02168-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-019-02168-z

Keywords

Search

Navigation